Knappe D - Search Results

1

Novel apidaecin 1b analogs with superior serum stabilities for treatment of infections by gram-negative pathogens.

Berthold N, Czihal P, Fritsche S, Sauer U, Schiffer G, Knappe D, Alber G, Hoffmann R. Berthold N, et al. Among authors: knappe d. Antimicrob Agents Chemother. 2013 Jan;57(1):402-9. doi: 10.1128/AAC.01923-12. Epub 2012 Oct 31. Antimicrob Agents Chemother. 2013. PMID: 23114765 Free PMC article.

2

Isolation, purification and de novo sequencing of TBD-1, the first beta-defensin from leukocytes of reptiles.

Stegemann C, Kolobov A Jr, Leonova YF, Knappe D, Shamova O, Ovchinnikova TV, Kokryakov VN, Hoffmann R. Stegemann C, et al. Among authors: knappe d. Proteomics. 2009 Mar;9(5):1364-73. doi: 10.1002/pmic.200800569. Proteomics. 2009. PMID: 19253295

3

Chemical modifications of short antimicrobial peptides from insects and vertebrates to fight multi-drug resistant bacteria.

Knappe D, Stegemann C, Nimptsch A, Kolobov A Jr, Korableva E, Shamova O, Kokryakov VN, Hoffmann R. Knappe D, et al. Adv Exp Med Biol. 2009;611:395-6. doi: 10.1007/978-0-387-73657-0_172. Adv Exp Med Biol. 2009. PMID: 19400239 No abstract available.

4

Oncocin (VDKPPYLPRPRPPRRIYNR-NH2): a novel antibacterial peptide optimized against gram-negative human pathogens.

Knappe D, Piantavigna S, Hansen A, Mechler A, Binas A, Nolte O, Martin LL, Hoffmann R. Knappe D, et al. J Med Chem. 2010 Jul 22;53(14):5240-7. doi: 10.1021/jm100378b. J Med Chem. 2010. PMID: 20565063

5

Easy strategy to protect antimicrobial peptides from fast degradation in serum.

Knappe D, Henklein P, Hoffmann R, Hilpert K. Knappe D, et al. Antimicrob Agents Chemother. 2010 Sep;54(9):4003-5. doi: 10.1128/AAC.00300-10. Epub 2010 Jun 28. Antimicrob Agents Chemother. 2010. PMID: 20585128 Free PMC article.

6

Preclinical advantages of intramuscularly administered peptide A3-APO over existing therapies in Acinetobacter baumannii wound infections.

Ostorhazi E, Rozgonyi F, Sztodola A, Harmos F, Kovalszky I, Szabo D, Knappe D, Hoffmann R, Cassone M, Wade JD, Bonomo RA, Otvos L Jr. Ostorhazi E, et al. Among authors: knappe d. J Antimicrob Chemother. 2010 Nov;65(11):2416-22. doi: 10.1093/jac/dkq337. Epub 2010 Sep 1. J Antimicrob Chemother. 2010. PMID: 20810424 Free PMC article.

7

QCM-D fingerprinting of membrane-active peptides.

McCubbin GA, Praporski S, Piantavigna S, Knappe D, Hoffmann R, Bowie JH, Separovic F, Martin LL. McCubbin GA, et al. Among authors: knappe d. Eur Biophys J. 2011 Apr;40(4):437-46. doi: 10.1007/s00249-010-0652-5. Epub 2010 Dec 16. Eur Biophys J. 2011. PMID: 21161523

8

Bactericidal oncocin derivatives with superior serum stabilities.

Knappe D, Kabankov N, Hoffmann R. Knappe D, et al. Int J Antimicrob Agents. 2011 Feb;37(2):166-70. doi: 10.1016/j.ijantimicag.2010.10.028. Epub 2010 Dec 23. Int J Antimicrob Agents. 2011. PMID: 21185160

9

Rational design of oncocin derivatives with superior protease stabilities and antibacterial activities based on the high-resolution structure of the oncocin-DnaK complex.

Knappe D, Zahn M, Sauer U, Schiffer G, Sträter N, Hoffmann R. Knappe D, et al. Chembiochem. 2011 Apr 11;12(6):874-6. doi: 10.1002/cbic.201000792. Epub 2011 Mar 8. Chembiochem. 2011. PMID: 21387510 No abstract available.

10

Api88 is a novel antibacterial designer peptide to treat systemic infections with multidrug-resistant Gram-negative pathogens.

Czihal P, Knappe D, Fritsche S, Zahn M, Berthold N, Piantavigna S, Müller U, Van Dorpe S, Herth N, Binas A, Köhler G, De Spiegeleer B, Martin LL, Nolte O, Sträter N, Alber G, Hoffmann R. Czihal P, et al. Among authors: knappe d. ACS Chem Biol. 2012 Jul 20;7(7):1281-91. doi: 10.1021/cb300063v. Epub 2012 May 17. ACS Chem Biol. 2012. PMID: 22594381

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

155 results

Search Page